Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Shares Outstanding (2011 - 2026)

Iqvia Holdings' (IQV) quarterly Shares Outstanding (Entity) came in at $164.6 million in Q2 2026, down 3.18% year-over-year from $170.0 million in Q2 2025, and down 1.38% quarter-over-quarter from $166.9 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Shares Outstanding (2011 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Shares Outstanding (Entity) across 16 years of filings, most recently posting $164.6 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) fell 3.18% year-over-year to $164.6 million; the TTM figure through Jun 2026 stood at $164.6 million (down 3.18% YoY), while the FY2025 annual figure was $169.6 million, down 3.69% from the prior year.
  • Shares Outstanding (Entity) came in at $164.6 million for Q2 2026 at Iqvia Holdings, down from $166.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $189.3 million in Q1 2022 to a low of $164.6 million in Q2 2026.
  • Average Shares Outstanding (Entity) over 5 years is $178.8 million, with a median of $181.9 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Entity) retreated 0.44% in 2024 and declined 6.75% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $185.7 million in 2022, then retreated by 2.26% to $181.5 million in 2023, then dropped by 2.98% to $176.1 million in 2024, then decreased by 3.69% to $169.6 million in 2025, then decreased by 2.95% to $164.6 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $164.6 million in Q2 2026, $166.9 million in Q1 2026, and $169.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 166.10 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 28.17 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 78.42 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 48.02 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 94.80 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 355.16 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 62.09 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 13.90 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 46.38 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 5.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 166.10 Mn
Mar 31, 2026 168.40 Mn
Dec 31, 2025 171.90 Mn
Sep 30, 2025 170.20 Mn
Jun 30, 2025 171.80 Mn
Mar 31, 2025 175.70 Mn
Dec 31, 2024 181.30 Mn
Sep 30, 2024 182.10 Mn
Jun 30, 2024 182.20 Mn
Mar 31, 2024 181.90 Mn
Dec 31, 2023 183.80 Mn
Sep 30, 2023 182.90 Mn
Jun 30, 2023 184.40 Mn
Mar 31, 2023 185.80 Mn
Dec 31, 2022 187.60 Mn
Sep 30, 2022 186.50 Mn
Jun 30, 2022 188.30 Mn
Mar 31, 2022 190.00 Mn
Dec 31, 2021 191.40 Mn
Sep 30, 2021 191.50 Mn